Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol

Christian Reichel; Damir Erceg; Barbara Lorenc

Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol

Christian Reichel, Damir Erceg, Barbara Lorenc

Chemical Analytics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	163
Number of pages	172
Journal	Drug Testing and Analysis
Volume	2023
Issue number	15
Publication status	Published - 2023

Research Field

Seibersdorf Laboratories

Cite this

@article{9cc4ef4e3a25433bb618a7ea639efb5c,

title = "Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol",

author = "Christian Reichel and Damir Erceg and Barbara Lorenc",

year = "2023",

language = "English",

volume = "2023",

pages = "163",

journal = "Drug Testing and Analysis",

issn = "1942-7603",

publisher = "John Wiley and Sons Ltd",

number = "15",

}

Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol. / Reichel, Christian; Erceg, Damir; Lorenc, Barbara.
In: Drug Testing and Analysis, Vol. 2023, No. 15, 2023, p. 163.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol

AU - Reichel, Christian

AU - Erceg, Damir

AU - Lorenc, Barbara

PY - 2023

Y1 - 2023

M3 - Article

SN - 1942-7603

VL - 2023

SP - 163

JO - Drug Testing and Analysis

JF - Drug Testing and Analysis

IS - 15

ER -